Long-term clinical study on luteinising hormone-releasing hormone agonist depot formulation in the treatment of stage D prostatic cancer. The TAP-144-SR Study Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples